Medical

About Animas and AMSL

About Animas and Australasian Medical & Scientific Ltd.

Animas and Australasian Medical & Scientific Ltd (AMSL) are dedicated to making diabetes management easier through product innovation, exceptional customer support and customised education programs. Our mission is to improve the lifestyle of people with diabetes, reduce the long-term morbidity of the disease and lower healthcare costs.
Since the company's inception in 1996, Animas' innovations have set the standard for the industry. It began with the R1000 insulin pump, which featured many "firsts," including menu-driven operation, true waterproof status, multiple basal programs and smaller basal increments.

• June 2000: Animas launches R1000 infusion pump in America
• June 2001: Animas develops ezManager™ diabetes management software
• June 2002: Animas launches IR1000 insulin pump in America
• June 2003 : Animas develops ezManager Plus diabetes management software
• November 2003: Animas launches IR 1200 insulin pump in America
• May 2004: IR1000 insulin pump released in Australia by Australasian Medical & Scientific Ltd
• October 2004: Animas acquires MEMS technology
• December 2004: Animas launches IR 1250 insulin pump in America
• January 2005: IR1200 insulin pump released in Australia by Australasian Medical & Scientific Ltd
• July 2007: 2020 insulin pump released in Australia by Australasian Medical & Scientific Ltd

For further product detail on the Animas 2020 insulin pump, call us, or visit www.animascorp.com